WESTFIELD CAPITAL MANAGEMENT CO LP - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WESTFIELD CAPITAL MANAGEMENT CO LP ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$9,726,000
+34.1%
4,192,034
-10.4%
0.08%
+36.4%
Q4 2017$7,251,000
-29.9%
4,678,364
-3.7%
0.06%
-30.4%
Q3 2017$10,349,000
-56.7%
4,858,454
-8.1%
0.08%
-61.3%
Q2 2017$23,894,000
+62.2%
5,286,340
+8.0%
0.20%
+61.9%
Q1 2017$14,734,000
+5.1%
4,894,948
-3.6%
0.13%
+2.4%
Q4 2016$14,016,000
-17.0%
5,078,393
-5.9%
0.12%
-9.6%
Q3 2016$16,893,000
-15.6%
5,397,007
+38.1%
0.14%
-17.6%
Q2 2016$20,015,000
+23.3%
3,909,092
-1.5%
0.16%
+34.1%
Q1 2016$16,230,000
-47.9%
3,968,245
+3.3%
0.12%
-41.4%
Q4 2015$31,157,000
+14.6%
3,841,830
+19.2%
0.21%
+8.8%
Q3 2015$27,197,000
+5.0%
3,222,395
+17.0%
0.19%
+22.2%
Q2 2015$25,911,000
+25.1%
2,753,510
+23.1%
0.16%
+32.8%
Q1 2015$20,711,000
+47.2%
2,236,577
+47.0%
0.12%
+43.4%
Q4 2014$14,071,000
+115.6%
1,521,187
+108.1%
0.08%
+107.5%
Q3 2014$6,527,000
+200.0%
730,926
+163.7%
0.04%
+207.7%
Q2 2014$2,176,000
-8.3%
277,164
-7.6%
0.01%
-7.1%
Q1 2014$2,374,000300,0640.01%
Other shareholders
CARDIOME PHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,241,550$7,520,0004.03%
Tamarack Advisers, LP 1,875,000$4,350,0002.07%
CLOUGH CAPITAL PARTNERS L P 2,075,663$4,816,0000.46%
Rock Springs Capital Management LP 1,200,000$2,784,0000.12%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,192,034$9,726,0000.08%
PUTNAM INVESTMENTS LLC 3,092,133$7,174,0000.02%
Renaissance Technologies 528,913$1,227,0000.00%
SCOTIA CAPITAL INC. 19,120$44,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 51,200$118,0000.00%
WELLS FARGO & COMPANY/MN 700$2,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders